Type II diabetes mellitus (T2DM) is becoming an increasingly prevalent public health concern, affecting an estimated 7% of the global population. This number is rising rapidly and is commonly associated with risk factors such as food insecurity, sedentary lifestyles, obesity, and elevated oxidative stress.
T2DM is a metabolic disorder characterized by high blood glucose levels resulting from either insulin resistance or defects in insulin secretion. Recent findings suggest a rising incidence of T2DM among younger populations, highlighting the need for effective and accessible care, particularly in communities with limited access to pharmacological healing.
Conventional biomedical treatment typically includes both lifestyle modifications and pharmacologic interventions aimed at reducing blood glucose levels and counteracting hyperglycemia. Medications such as Metformin, which improves insulin sensitivity in the liver, and newer therapies such as GLP-1 receptor agonists, which stimulate insulin release and regulate appetite, address many of the primary effects of T2DM. Lifestyle modifications generally prioritize dietary changes to reduce sugar intake, regular exercise, and weight loss. Although these treatment options are often effective, they may be associated with long-term side effects and remain inaccessible to many populations experiencing disproportionately high rates of T2DM.
Integrative strategies that combine herbal medicine with pharmacological therapies may offer one of the most effective approaches to T2DM management by centering a multifaceted approach that incorporates diet, lifestyle changes, and pharmacotherapy. The following four studies highlight recent findings regarding the effectiveness, safety, and clinical applications of herbal medicine in T2DM treatment and management. Grounded in holistic and integrative strategies, herbal medicine may serve as a complementary therapy to reduce both the prevalence and harmful effects of T2DM.
Khan, Moien Abdul Basith, Muhammad Jawad Hashim, Jeffrey Kwan King, Romona Devi Govender, Halla Mustafa, and Juma Al Kaabi. “Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends.” Journal of Epidemiology and Global Health 10, no. 1 (2020): 107–11. https://doi.org/10.2991/jegh.k.191028.001.
The first study explores the literature on 16 medicinal plants to better understand their bioactive compounds and the mechanisms through which they exert antidiabetic effects.
The medicinal plants include, but are not limited to, Devil’s Horsewhip, garlic, aloe vera, Lal Chaulai, the cashew tree, and members of the Annonaceae family. Many of these plants have been administered orally as extracts or whole-plant preparations in both animal and human studies. Results commonly demonstrate reductions in blood glucose levels, oxidative stress, and cholesterol, as well as enhanced pancreatic insulin protein expression. These findings suggest broader antioxidant and antidiabetic activities, showing high therapeutic potential for the treatment of T2DM. Although existing literature is often limited by small sample sizes, short experimental durations, and a reliance on animal models, these findings highlight promising opportunities for future biotechnological applications of plant-based T2DM management.
The second study reviews the clinical potential of flavonoids, a group of bioactive compounds found in a variety of medicinal plants, in the management of T2DM. Flavonoids are widely recognized for their antidiabetic properties, including lowering blood glucose levels and enhancing insulin secretion. Compounds such as apigenin, arbutin, catechines, and cyanidin are commonly associated with metabolic regulation through pathways such as glycolysis and gluconeogenesis. Current research suggests that plant-derived flavonoids may modulate insulin pathways, GLUT-4 receptor translocation, and provide anti-inflammatory and immunomodulatory effects, addressing major contributors to T2DM, including obesity, aging, and high oxidative stress. Combination therapies appear especially promising, pairing flavonoid supplementation with conventional diabetes medications to enhance therapeutic outcomes. However, existing research lacks long-term supplementation trials and comprehensive safety data necessary to determine their sustained glucose-regulating effects. Future research should further investigate the synergistic effects of these integrative treatment approaches.
The third article compares the effectiveness of pharmacological therapies with herbal remedies in the management of T2DM. Standard pharmacological treatment relies on Metformin, a first-line medication that may produce harmful side effects. Alternatively, Moringa oleifera has emerged as a promising herbal intervention for non-insulin-dependent diabetes mellitus. Findings suggest that Moringa oleifera may improve insulin sensitivity, regulate blood glucose levels, and reduce oxidative stress. Moringa leaf extract has demonstrated fewer adverse effects than conventional pharmacological therapies, potentially providing a safer complementary treatment option. Research further indicates that moringa leaf extract is particularly effective as an adjunctive therapy, exhibiting favorable safety ratings. These discoveries suggest that herbal medicine may offer safer complementary alternatives to existing pharmacological diabetes treatments.
The fourth study examines how microbiota-short-chain fatty acid (SFCA)–G protein-coupled receptors (GPRs) signaling pathway mediates the antidiabetic effects of mulberry leaves in T2DM. In this model, mice with T2DM were assigned to receive one of four formulas for ten consecutive weeks: mulberry leaf water extract (MLWE) and ethanol extract (MLEE), metformin (Glucophage), or distilled water. Metabolic parameters were measured, and microbiota depletion experiments were conducted to confirm the antidiabetic effects of MLWE-regulated gut microbiota. This study found that the mice receiving MLWE and MLEE exhibited improved insulin sensitivity and reduced expression of pro-inflammatory factors. These outcomes provide evidence that mulberry leaf may serve as an effective antidiabetic therapy. Future studies should extend these findings through human clinical trials to evaluate the efficacy and safety of MLWE in the treatment and management of T2DM.
